Interchangeable Biosimilars

FDA approval of interchangeable biosimilars can increase patient access to critical treatments at potentially lower costs. When a biosimilar is approved as interchangeable, it may be substituted for the reference product at the pharmacy without the intervention of the prescriber, depending on state pharmacy laws. This video explains more about the FDA approval of interchangeable biosimilars and that an interchangeable biosimilar is not safer or more effective than other biosimilars. Biologics are among the fastest growing segments of the prescription product market- learn more about biosimilars and how they may provide increased access to patients and potentially lower costs.

For more information, visit https://www.fda.gov/biosimilars